Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: Implication in the evolution of multidrug resistance in tumor cells

Anti-Cancer Drugs

Volumn 19, Issue 8, 2008, Pages 793-804

  Singh, Vivek ^a   Singh, Mahendra Pal ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cisplatin; Doxorubicin; Methotrexate; Multidrug resistance; T cell lymphoma; Tumor progression

Indexed keywords

BETA ACTIN; CISPLATIN; DOXORUBICIN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GLYCOPROTEIN P; MESSENGER RNA; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL CYCLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; HOST; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL TIME; T CELL LYMPHOMA; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; ANIMAL; ASCITES FLUID; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL COUNT; DISEASE COURSE; DNA FRAGMENTATION; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ASCITIC FLUID; BLOTTING, WESTERN; CELL COUNT; CYTOKINES; DISEASE PROGRESSION; DNA FRAGMENTATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INDICATORS AND REAGENTS; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES;

EID: 53749103911     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32830ce4f5     Document Type: Article

References (37)

1. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, et al. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 1998; 106:289-295.
2. Bishopric NH, Discher DJ, Kaiser S, Hernandez O, Sato B, Zang J. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999; 104:239-252.
3. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002; 3:420-425.
4. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98:2603-2614.
5. Singh V, Singh SM. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs 2007; 18:1123-1132.
6. Sprague LD, Mengele K, Schilling D, Geurts-Moespot A, Sweep FC, Stadler P. Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells. Oncology 2006; 71:282-291.
7. Pfäfflin A, Brodbeck K, Heilig C, Häring H, Schleicher E, Weigert C. Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1α. Cell Physiol Biochem 2006; 18:199-210.
8. Armitage JO, Vose JM, Weisenburger DD. Towards understanding the peripheral T-cell lymphomas. Ann Oncol 2004; 15:1447-1449.
9. Zhou J, Mauerer K, Farina L, Gribben JG. The role of the tumor microenvironment in hematological malignancies and implication for therapy. Front Biosci 2005; 10:1581-1596.
10. Gupta V, Singh SM. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. J Reprod Immunol 2007; 74:90-102.
11. Gupta V, Singh SM. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma. J Biomed Sci 2007;15:147-168.
12. Singh MP, Rai AK, Singh SM. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones. J Reprod Immunol 2005; 65:17-32.
13. Kumar A, Singh SM. Effect of tumor growth on the blastogenic response of splenocytes: a role of macrophage derived nitric oxide. Immunol Invest 1996; 25:413-423.
14. Bharti A, Singh SM. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T-cell lymphoma: the involved mechanisms. Nitric Oxide 2003; 8:75-82.
15. Singh MP, Sharma H, Singh SM. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines. Cancer Invest 2006; 24:601-610.
16. Singh MP, Singh G, Singh SM. Paraneoplastic neurodegeneration in a murine host following progressive growth of a spontaneous T-cell lymphoma: role of proinflammatory internal responses. Neuroimmunomodulation 2006; 13:122-132.
17. Parajuli P, Singh SM, Kumar A. Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Int J Immunopharmacol 1995; 17:1-7.
18. Sellins KS, Cohen JJ. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987; 139:199-206.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65:55-63.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 1976; 72:248-254.
21. Davis BJ. Disc electrophoresis-II. Method and application to human serum proteins. Ann N Y Acad Sci 1964; 121:404-414.
22. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR. 2-deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 2007; 67:3364-3370.
23. Tanimura S, Hirano AI, Hashizume J, Yasunaga M, Kawabata T, Ozaki K, Kohno M. Anticancer drugs up-regulate HspBP1 and thereby antagonize the prosurvival function of Hsp70 in tumor cells. J Biol Chem 2007; 282:35430-35439.
24. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukocyte Biol 2007; 81:15-27.
25. Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA. Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res 2005; 65:2001-2008.
26. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, et al. The chaperone function of hsp70 is required for protection against stress induced apoptosis. Mol Cell Biol 2000; 20:7146-7159.
27. Goetz MP, Toft DO, Ames MM, Erlichman C. The Hsp90 chaperone complex as a novel target for cancer therapy. Ann Oncol 2003; 14:1169-1176.
28. Sreedhar AS, Kalmár E, Csermely P, Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 2004; 562:11-15.
29. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007; 37:14-16.
30. Davidoff AM, Iglehart JD, Marks JR. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci 1992; 89:3439-3442.
31. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10:263-274.
32. Borsellino N, Belldegrun A, Bonavida B. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 1995; 55:4633-4639.
33. Yusuf RZ, Duan Z, Lamendola DE, Penson RT, Seiden MV. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets 2003; 3:1-19.
34. Steiner T, Junker U, Henzgen B, Nuske K, Durum SK, Schubert J. Interferonalpha suppresses the antiapoptotic effect of NF-κB and sensitizes renal cell carcinoma cells in vitro to chemotherapeutic drugs. Eur Urol 2001; 39: 478-483.
35. Kim SH, Hur WY, Kang CD, Lim YS, Kim DW, Chung BS. Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells. Cancer Lett 1997; 115:9-14.
36. Shen F, Chu S, Bence AK, Bailey B, Xue X, Erickson PA, et al. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J Pharmacol Exp Ther 2008; 324:95-102.
37. Niethammer AG, Wodrich H, Loeffler M, Lode HN, Emmerich K, Abdollahi A, et al. Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy. FASEB J 2005; 19:158-169.